Insider trades
Johanna Mercier, Chief Officer of Gilead Sciences GILD, has filed 0 purchases and 35 sales on the open market. Over the past 12 months that comes to a net sale of $13.8M. The latest trade was on 06/15.
Johanna Mercier
Chief Comm & Corp Aff Officer
- Company
- Gilead Sciences GILD
- First filing
- 23/01/26
- Trades
- 134 trades
- Buys / sales
- 0 / 35
- 12-month net buying
- −$13.8M
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
GILD | Open-market sale10b5-1 plan | 06/15 | 06/16 | 3,000 sh3 trades | $123.92avg. | $371,771.6 | −2.4% |
GILD | Open-market sale10b5-1 plan | 05/15 | 05/18 | 28,000 sh4 trades | $131.29avg. | $3,676,146.86 | −18.2% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 04/15 | 04/16 | 3,000 sh | $140.96 | $422,880 | −2.3% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 03/16 | 03/17 | 3,000 sh | $144.23 | $432,690 | −2.2% |
GILD | Open-market sale10b5-1 plan | 02/17 | 02/18 | 28,000 sh3 trades | $154.44avg. | $4,324,186.35 | −18.9% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 01/15 | 01/16 | 3,000 sh | $124.31 | $372,930 | −2.8% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/12/15 | 25/12/16 | 3,000 sh | $122.00 | $366,000 | −2.7% |
GILD | Open-market sale10b5-1 plan | 25/11/17 | 25/11/18 | 28,000 sh2 trades | $125.87avg. | $3,524,304.68 | −20.7% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/10/15 | 25/10/16 | 3,000 sh | $118.08 | $354,240 | −2.7% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/09/15 | 25/09/16 | 3,000 sh | $113.57 | $340,710 | −2.6% |
GILD | Open-market sale10b5-1 plan | 25/08/15 | 25/08/18 | 28,000 sh6 trades | $118.53avg. | $3,318,898 | −19.7% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/07/15 | 25/07/16 | 3,000 sh | $111.03 | $333,090 | −2.5% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 25/06/16 | 25/06/17 | 3,000 sh | $110.17 | $330,510 | −2.4% |
GILD | Open-market sale10b5-1 plan | 25/05/22 | 25/05/23 | 28,000 sh3 trades | $107.52avg. | $3,010,560 | −18.8% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 24/11/06 | 24/11/07 | 5,000 sh | $91.28 | $456,400 | −6.4% |
GILD | Open-market sale10b5-1 plan | 24/09/12 | 24/09/13 | 29,357 sh2 trades | $83.78avg. | $2,459,576.75 | −27.3% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 24/08/28 | 24/08/29 | 9,513 sh | $78.03 | $742,299.39 | −8.3% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 24/08/13 | 24/08/14 | 5,490 sh | $73.98 | $406,150.2 | −4.6% |
Gilead SciencesGILD | Open-market sale10b5-1 plan | 24/01/09 | 24/01/10 | 8,242 sh | $85.23 | $702,465.66 | −9.1% |